Vision
"An AI-powered neuroimaging platform redefining precision treatment for Alzheimer’s disease."
Why?
Alzheimer’s treatment has entered a new era yet only a limited number of patients truly benefit from current therapies. There is a growing need for precise and accessible technology that can predict therapeutic effectiveness and maximize patient outcomes.
How?
By analyzing MRI scans, an advanced AI model predicts amyloid and tau burden to identify the golden therapeutic window the optimal stage at which a patient can most benefit from treatment.
What?
An AI software platform that enables biomarker-based diagnosis and treatment suitability prediction using MRI alone eliminating the need for costly PET scans and making advanced Alzheimer’s care accessible to hospitals worldwide.